Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris

Archives of Dermatological Research

Volumn 305, Issue 3, 2013, Pages 263-267

  Chen, Tao ^a   Guo, Zai Pei ^a   Li, Li ^a   Wang, Ling ^a   Jia, Rui Zhen ^b   Cao, Na ^a   Qin, Sha ^a   Li, Meng Meng ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Atopic dermatitis; High mobility group box 1; Psoriasis vulgaris

Indexed keywords

CYTOPLASM PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CELL NUCLEUS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS VULGARIS; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ADULT; CELL NUCLEUS; CYTOPLASM; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; PSORIASIS; SKIN; YOUNG ADULT;

EID: 84876493771     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1330-0     Document Type: Article

References (17)

1. Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M (2010) HMGB1 in systemic lupus Erythematosus: its role in cutaneous lesions development. Autoimmun Rev 9:661-665
2. Anderson KS, Petersson S, Wong J, Shubbar E, Lokko NN, Carlström M et al (2010) Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris. Br J Dermatol 163:1085-1089
3. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH et al (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652-2660
4. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009) Human Langerhans cells induce distinct IL-22-producing CD4 + T cells lacking IL-17 production. Proc Natl Acad Sci USA 106:21795-21800
5. Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB et al (2007) Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13:210-215
6. He Z, Jin L, Liu ZF, Hu L, Dang EL, Feng ZZ et al (2012) Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis. Br J Dermatol 167:191-193
7. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342
8. Oktayoglu P, Em S, Tahtasiz M, Bozkurt M, Ucar D, Yazmalar L et al (2012) Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life. Rheumatol Int. doi: 10.1007/s00296-012-2578-y
9. Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M et al (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52:3639-3645
10. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H et al (2003) IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170:3890-3897
11. Rossini A, Zacheo A, Mocini D, Totta P, Facchiano A, Castoldi R et al (2008) HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 44:683-693
12. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T et al (2006) Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12:7666-7670
13. Schierbeck H, Lundbäck P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U et al (2011) Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mol Med 17:1039-1044
14. Shi Y, Sandoghchian Shotorbani S, Su Z, Liu Y, Tong J, Zheng D et al (2012) Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis. Clin Dev Immunol 2012:295081
15. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R et al (2008) High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 128:1545-1553
16. Su Z, Sun C, Zhou C, Liu Y, Zhu H, Sandoghchian S et al (2011) HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Eur J Immunol 41:3586-3595
17. Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B et al (2011) TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 127:200-207